https://www.selleckchem.com/pr....oducts/mavoglurant.h
02±1.45) compared to patients under first-line treatment (30.57±1.68, p less then 0.001) and to patients with SPMS (29±1.56, p=0.02), and a lower mean L-selectin expression in (69.39±1.73) compared to patients under first-line treatment (79.1±1.17, p=0.003). A negative correlation between the relative frequency of CD4+CD62L+ T-cells and the absolute lymphocyte counts (Pearson's r=0.367, p=0.033) was observed.Discussion We hereby provide mechanistic insight in a possible pathway implicated in NTZ-related PML risk. These results furth
Like
Comment
Share
